Sign in

CIK 0001080014

  • Large accelerated filer

Innoviva, Inc.

Sign in to watch
Ticker
INVA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943265960
Phone
+1 650-238-9600
Business address
1350 OLD BAYSHORE HIGHWAY, SUITE 400, BURLINGAME, CA, 94010
Former names
THERAVANCE INC, ADVANCED MEDICINE INC
  1. 3 Insider Initial Statement of Ownership
  2. 4 Shares withheld for taxes Chief Accounting Officer gave up 602 shares (to pay taxes)
  3. 4 Grant or award Interim PEO acquired 3,000 shares (grant or award)
  4. 4 Shares withheld for taxes Chief Accounting Officer gave up 600 shares (to pay taxes)
  5. 4 Grant or award Director acquired 16,399 shares (grant or award)
  6. 4 Grant or award Director acquired 16,399 shares (grant or award)
  7. 4 Grant or award Director acquired 16,399 shares (grant or award)
  8. 4 Grant or award Director acquired 16,399 shares (grant or award)
  9. 4 Grant or award Director acquired 16,399 shares (grant or award)
  10. 4 Shares withheld for taxes Chief Accounting Officer gave up 601 shares (to pay taxes)
  11. 4 Grant or award Chief Accounting Officer acquired 8,154 shares (grant or award)
  12. 4 Grant or award Interim PEO acquired 14,677 shares (grant or award)
  13. 4 Open-market buy Director bought 15,000 shares at $15.90 ($238,500)
  14. 4 Open-market sale Chief Accounting Officer sold 5,617 shares at $16.00 ($89,872)
  15. 4 Shares withheld for taxes Chief Accounting Officer gave up 1,353 shares (to pay taxes)
  16. 4 Open-market buy Director bought 10,000 shares at $14.90 ($148,958)
  17. 4/A Shares withheld for taxes Interim PEO gave up 3,093 shares (to pay taxes)
  18. 4 Open-market buy Interim PEO bought 7,000 shares at $14.80 ($103,600)
  19. 4 Shares withheld for taxes Chief Accounting Officer gave up 540 shares (to pay taxes)
  20. 4 Grant or award Chief Accounting Officer acquired 1,779 shares (grant or award)

Page 8 of 39 · 776 filings